𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Timeline: The discovery of receptor tyrosine kinases: targets for cancer therapy

✍ Scribed by Gschwind, Andreas; Fischer, Oliver M.; Ullrich, Axel


Book ID
109947165
Publisher
Nature Publishing Group
Year
2004
Tongue
English
Weight
220 KB
Volume
4
Category
Article
ISSN
1474-1776

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Targeting EGFR and HER-2 receptor tyrosi
✍ Shantaram Kamath; John K. Buolamwini πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 472 KB

Conventional anticancer therapy using cytotoxic drugs lacks selectivity and is prone to toxicity and drug resistance. Anticancer therapies targeting aberrant growth factor receptor signaling are gaining interest. The erbB receptor family belongs to the type I, the receptor tyrosine kinases class, an